GRQ Biotech Advisors

GRQ Biotech Advisors is a consulting firm that operates as a network of regulatory, compliance, and quality experts serving the biotechnology and pharmaceutical industries. According to its own description, the firm provides "innovate, science and risk-based approaches for development, approvals and lifecycle management of biologics, small molecules, and vaccines." Rather than functioning as a single large bureaucracy, GRQ positions itself as an assembled network of advisors whose collective expertise spans drug development from pre-approval through post-approval regulatory and quality strategy, planning, and execution. The firm's service portfolio is organized around the practical milestones of pharmaceutical development. It offers guidance on IND, NDA, and BLA submissions, FDA liaison and health-authority interactions, regulatory and CMC strategy, quality compliance, combination products, due diligence for biotech investments, business development, and product development. This range suggests a client base of emerging and mid-sized biotech ventures that need external regulatory and quality capability to move programs from concept toward market authorization. Geographically, GRQ states that it has extensive experience providing regulatory and quality solutions across all geographies, with emphasis on the United States, the European Union, Japan, Brazil, and China. It also advises companies located in the EU, India, China, and Japan on regulatory, CMC, compliance, and quality solutions for successful submission, approval, and lifecycle management in the US and EU. Through partnerships with an extensive network of collaborators, the firm says it can provide end-to-end support, including authoring and publishing for regulatory filings across clinical, preclinical, and CMC domains. GRQ Biotech Advisors is a privately held consultancy and is not known to be listed on any public stock exchange. Its public identity rests on its official website, grqconsulting.com, and a Wikidata entry describing it as a "biotechnology regulatory and quality compliance consulting firm." The firm does not appear to be a product manufacturer; its offering is expert advisory service rather than a physical product brand.

GRQ Biotech Advisors presents itself as a network of regulatory, compliance, and quality experts rather than a traditional hierarchical consultancy. Its public materials describe a practice built around providing science- and risk-based approaches for the development, approval, and lifecycle management of biologics, small molecules, and vaccines. The firm's advisors are described as offering expertise in drug development and in regulatory strategy from pre-approval through post-approval phases. The firm's service lines reflect the operational needs of biotech and pharmaceutical sponsors. These include business development support for biotech ventures, combination products compliance, due diligence for biotech investments, FDA liaison, IND/NDA/BLA submission guidance, product development, quality compliance, and regulatory and CMC consulting. This breadth indicates a practice designed to support clients across the full arc of a product's regulatory life rather than a single narrow niche. Internationally, GRQ states that it has extensive experience providing regulatory and quality solutions for all geographies, with emphasis on the United States, the European Union, Japan, Brazil, and China. It also provides expertise to companies located in the EU, India, China, and Japan on regulatory, CMC, compliance, and quality solutions for successful submission, approval, and lifecycle management in the US and EU. The firm says it provides full support for IND/NDA/BLA submissions and health authority liaison and interactions. Through partnerships with an extensive network of collaborators, it can provide end-to-end support, including authoring and publishing for regulatory filings across clinical, preclinical, and CMC areas. No founding date, founder names, headquarters location, or ownership structure is disclosed in the available public evidence. The firm is described in Wikidata as a "biotechnology regulatory and quality compliance consulting firm," and its official website is grqconsulting.com. It is not known to be publicly listed. The available record is therefore limited to the firm's self-described capabilities and market focus rather than a detailed corporate chronology.

A network-based advisory firm offering science- and risk-based regulatory, compliance, and quality expertise for biologics, small molecules, and vaccines across major global markets.

• Regulatory strategy and submissions (IND, NDA, BLA)

  Expert guidance on investigational new drug, new drug, and biologics license applications for a smooth regulatory pathway.

• Regulatory and CMC consulting

  Navigating complex regulatory and chemistry, manufacturing, and controls landscapes with precision and expertise.

• Quality compliance

  Upholding excellence through rigorous quality compliance for biotech products.

• FDA liaison

  Facilitating seamless FDA liaison for swift regulatory navigation and approvals.

• Combination products

  Pioneering integration for combination products with expert compliance and innovation.

• Due diligence

  Meticulous due diligence ensuring biotech investments are secure and promising.

• Business development

  Elevating biotech ventures with strategic business development for groundbreaking success.

• Product development

  Transforming ideas into market-ready products with comprehensive development strategies.

1. 1Home - GRQ Biotech Advisorsgrqconsulting.com
2. 2About Us - GRQ Biotech Advisorsgrqconsulting.com
3. 3GRQ Biotech Advisors - Wikidatawikidata.org